Gene · 2131
Papers1,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systemic Lupus Erythematosus Patients with DNASE1L3·Deficiency Have a Distinctive and Specific Genic Circular DNA Profile in Plasma. | Cells | 2023 | 37048133 | PubTator, text mining | PubMed |
| Screening of single nucleotide polymorphisms within HLA region related to hematopoietic stem cell transplantation using MassARRAY technology. | Sci Rep | 2023 | 37041193 | PubTator, text mining | PubMed |
| Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer. | Cancer Med | 2023 | 37017469 | PubTator, text mining | PubMed |
| Exostosin 1 Knockdown Induces Chemoresistance in MV3 Melanoma Cells by Upregulating JNK and MEK/ERK Signaling. | Int J Mol Sci | 2023 | 36982528 | PubTator, text mining | PubMed |
| Detecting Embryo Developmental Potential by Single Blastomere RNA-Seq. | Genes (Basel) | 2023 | 36980841 | PubTator, text mining | PubMed |
| Regulation of ErbB Receptors by the Ca2+ Sensor Protein Calmodulin in Cancer. | Biomedicines | 2023 | 36979639 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction, Oxidative Stress, and Therapeutic Strategies in Diabetes, Obesity, and Cardiovascular Disease. | Antioxidants (Basel) | 2023 | 36978905 | PubTator, text mining | PubMed |
| Alpha 2-macroglobulin acts as a clearance factor in the lysosomal degradation of extracellular misfolded proteins. | Sci Rep | 2023 | 36977730 | PubTator, text mining | PubMed |
| Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways. | Cancer Discov | 2023 | 36977461 | PubTator, text mining | PubMed |
| Hsa_circ_0008035 Knockdown Inhibits Bladder Cancer Progression through miR-1184/RAP2B Axis. | Urol Int | 2023 | 36958293 | PubTator, text mining | PubMed |
A Diagnostic and Therapeutic Dilemma Concerning Exostosin 1/Exostosin 2-associated Lupus-like Membranous Nephropathy with Positive Antinuclear Antibody in an Elderly Man with Various Immune Abnormalities. | Intern Med | 2023 | 36948625 | PubTator, text mining | PubMed |
| Novel Treatments Paradigms: Membranous Nephropathy. | Kidney Int Rep | 2023 | 36938069 | PubTator, text mining | PubMed |
| Regulatory mechanisms of microRNAs in endocrine disorders and their therapeutic potential. | Front Genet | 2023 | 36896239 | PubTator, text mining | PubMed |
| MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles. | iScience | 2023 | 36879816 | PubTator, text mining | PubMed |
| Clinico-pathological features of diabetic and non-diabetic renal diseases in type 2 diabetic patients: a retrospective study from a 10-year experience in a single center. | Int Urol Nephrol | 2023 | 36879071 | PubTator, text mining | PubMed |
| The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics. | Carbohydr Polym | 2023 | 36876764 | PubTator, text mining | PubMed |
| A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy. | Case Rep Nephrol | 2023 | 36873956 | PubTator, text mining | PubMed |
| Venous malformation may be a feature of EXT1-related hereditary multiple exostoses: A report of two unrelated probands. | Am J Med Genet A | 2023 | 36869625 | PubTator, text mining | PubMed |
| Expanding the clinical and molecular features of trichorhino- phalangeal syndrome with a novel variant. | Turk J Pediatr | 2023 | 36866988 | PubTator, text mining | PubMed |
| The Many Faces of NELL1 MN. | Clin Kidney J | 2023 | 36865014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2131/papers?page=12